← Back to Browse

Boston Scientific Corporation

BSX • Healthcare

80
Grade B
Compass
Current Price
$53.06
Market Cap
$141.4B

About Boston Scientific Corporation

Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular.

Quality Assessment

Boston Scientific Corporation is a above-average quality healthcare company with a Compass Score of 80. This stock shows solid fundamentals with room for improvement in some areas. Worth considering for a diversified portfolio.

Score Breakdown

The Compass Score is based on 6 quality factors identified by academic research.

Click any factor to see detailed metrics

Valuation Metrics

Click any metric for details

Technical Overview

Click any metric for details

Wall Street View

Consensus
N/A
Analysts
24
Price Target
🔒
Upside
🔒

Growth Projections

Projected EPS Growth
🔒
Projected Revenue Growth
🔒

Financial Health

Click any metric for details

Similar High-Quality Stocks

ONC

BeOne Medicines Ltd.

95
$316.55
Grade A

ALKS

Alkermes plc

95
$38.91
Grade A

ARDT

Ardent Health Partners, LLC

95
$9.91
Grade A

ARWR

Arrowhead Pharmaceuticals, Inc.

95
$77.88
Grade A

CPRX

Catalyst Pharmaceuticals, Inc.

95
$31.16
Grade A

CSBR

Champions Oncology, Inc.

95
$6.02
Grade A

Important Disclaimer

The Compass Score is for educational purposes only and does not constitute financial advice. Past performance does not guarantee future results. Always do your own research and consider consulting a financial advisor before making investment decisions.